Document is current
Any future updates will be listed below
-
Authors
Strischewski, David
Kalmar, Amira
Guest, Paul C.
Dobrowolny, Henrik
Meyer-Lotz, Gabriela
Schiffner, Conrad J.
Jordan, Wolfgang
Müller, Ulf J.
Borucki, Katrin
Böttcher, Michael
Relja, Borna
Steiner, Johann https://orcid.org/0000-0002-2611-2268
-
Funding
Funding for this research was provided by:
Cheplapharm Arzeimittel (CMZ study)
Otto-von-Guericke-Universität Magdeburg
- License Information
-
More Information
Article History
Received: 28 March 2024
Accepted: 27 May 2024
First Online: 8 June 2024
Declarations
:
: None of the authors declare any competing interests. The study design, data collection, interpretation of results, and manuscript preparation were not influenced by the funding source.
: Ethics Committee of the Otto von Guericke University in Magdeburg (reference number 80/17).
